Citadel Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-330,234
| Closed | -$7.8M | – | 15848 |
|
|
2023
Q4 | $7.8M | Buy |
330,234
+216,927
| +191% | +$3.86M | 0.01% | 3168 |
|
|
2023
Q3 | $1.69M | Sell |
113,307
-336,155
| -75% | -$4.46M | ﹤0.01% | 5530 |
|
|
2023
Q2 | $4.92M | Buy |
449,462
+123,576
| +38% | +$1.15M | 0.01% | 3682 |
|
|
2023
Q1 | $2.84M | Sell |
325,886
-1,034,929
| -76% | -$8.28M | ﹤0.01% | 4731 |
|
|
2022
Q4 | $8.53M | Buy |
1,360,815
+9,158
| +0.7% | +$34.8K | 0.01% | 3038 |
|
|
2022
Q3 | $4.73M | Buy |
1,351,657
+41,780
| +3% | +$150K | 0.01% | 3964 |
|
|
2022
Q2 | $3.86M | Buy |
1,309,877
+343,000
| +35% | +$819K | 0.01% | 4280 |
|
|
2022
Q1 | $3.01M | Buy |
966,877
+280,443
| +41% | +$883K | ﹤0.01% | 5180 |
|
|
2021
Q4 | $2.32M | Buy |
686,434
+575,805
| +520% | +$2.19M | ﹤0.01% | 5901 |
|
|
2021
Q3 | $404K | Sell |
110,629
-241,668
| -69% | -$952K | ﹤0.01% | 10388 |
|
|
2021
Q2 | $1.54M | Sell |
352,297
-1,228,678
| -78% | -$5.45M | ﹤0.01% | 7266 |
|
|
2021
Q1 | $7.18M | Sell |
1,580,975
-942,450
| -37% | -$5.07M | 0.01% | 3527 |
|
|
2020
Q4 | $14.5M | Buy |
2,523,425
+301,870
| +14% | +$2.29M | 0.02% | 2172 |
|
|
2020
Q3 | $16.1M | Sell |
2,221,555
-478,543
| -18% | -$2.56M | 0.02% | 1766 |
|
|
2020
Q2 | $9.42M | Buy |
2,700,098
+35,865
| +1% | +$103K | 0.01% | 2291 |
|
|
2020
Q1 | $3.94M | Sell |
2,664,233
-192,055
| -7% | -$322K | 0.01% | 3057 |
|
|
2019
Q4 | $5.6M | Buy |
2,856,288
+563,948
| +25% | +$2.12M | 0.01% | 2937 |
|
|
2019
Q3 | $11.7M | Sell |
2,292,340
-27,794
| -1% | -$168K | 0.01% | 2034 |
|
|
2019
Q2 | $16.6M | Sell |
2,320,134
-485,338
| -17% | -$5.5M | 0.02% | 1609 |
|
|
2019
Q1 | $37.3M | Buy |
2,805,472
+1,379,650
| +97% | +$14.7M | 0.05% | 865 |
|
|
2018
Q4 | $11.2M | Buy |
1,425,822
+468,574
| +49% | +$4.46M | 0.02% | 1771 |
|
|
2018
Q3 | $10.6M | Sell |
957,248
-957,559
| -50% | -$11.9M | 0.01% | 2027 |
|
|
2018
Q2 | $25.7M | Buy |
1,914,807
+846,407
| +79% | +$10.6M | 0.03% | 1115 |
|
|
2018
Q1 | $13.9M | Buy |
1,068,400
+374,148
| +54% | +$4.65M | 0.02% | 1430 |
|
|
2017
Q4 | $6.39M | Buy |
694,252
+54,225
| +8% | +$463K | 0.01% | 2183 |
|
|
2017
Q3 | $5.16M | Buy |
+640,027
| New | +$4.33M | 0.01% | 2279 |
|
|
2017
Q2 | – | Sell |
-16,404
| Closed | -$71K | – | 8345 |
|
|
2017
Q1 | $71K | Buy |
+16,404
| New | +$47.1K | ﹤0.01% | 6963 |
|
|
2016
Q4 | – | Sell |
-12,692
| Closed | -$25K | – | 8150 |
|
|
2016
Q3 | $25K | Sell |
12,692
-14,358
| -53% | -$28.6K | ﹤0.01% | 6995 |
|
|
2016
Q2 | $47K | Buy |
27,050
+16,071
| +146% | +$33.3K | ﹤0.01% | 6423 |
|
|
2016
Q1 | $15K | Buy |
+10,979
| New | +$13.6K | ﹤0.01% | 6549 |
|
|
2015
Q2 | – | Sell |
-26,373
| Closed | -$183K | – | 9220 |
|
|
2015
Q1 | $183K | Buy |
+26,373
| New | +$253K | ﹤0.01% | 6285 |
|